Code | 83444 | ||||||||||
MA number | 59/0291/95-S | ||||||||||
Product Form: | sus inj 20x0,5 ml/40 I.U. (striekačka) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | National | ||||||||||
MAH, country: | Sanofi Pasteur , France | ||||||||||
Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Intramuscular and subcutaneous use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 08.06.1995 |
SPC: | SPC_TETAVAX_11.2023.pdf |
PIL: | PIL_TETAVAX_11.2023.pdf |
Safety feature | Yes |
Data update: | 22.01.2018 |